HLA-DR antibody [LN3] (FITC), IgG2b, Mouse, Monoclonal

Produktübersicht

• Artikelname: HLA-DR antibody [LN3] (FITC), IgG2b, Mouse, Monoclonal
• Artikelnummer: GTX01489-06
• Hersteller Artikelnummer: GTX01489-06
• Alternativnummer: GTX01489-06-100
• Hersteller: GeneTex
• Wirt: Mouse
• Kategorie: Antikörper
• Applikation: FC
• Spezies Reaktivität: Human
• Konjugation: FITC
• Alternative Synonym: major histocompatibility complex, class II, DR alpha , major histocompatibility complex, class II, DR beta 1 , major histocompatibility complex, class II, DR beta 3 , major histocompatibility complex, class II, DR beta 4 , major histocompatibility complex, class II, DR beta 5 , HLA-DRA1 , DRB1 , HLA-DR1B , HLA-DRB , SS1 , DRB3 , HLA-DPB1 , HLA-DR1B , HLA-DR3B , DR4 , DRB4 , HLA-DR4B

Produktbeschreibung

The LN3 antibody reacts with a member of the human MHC Class II antigens, HLA-DR. The HLA-DR antigen is expressed on human antigen presenting cells including B lymphocytes, monocytes, macrophages, dendritic cells, and activated T lymphocytes. HLA-DR is a dimeric protein composed of alpha and beta subunits and is involved in the presentation of peptide antigens to CD4+ T cells.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 0.05 mg/ml (Please refer to the vial label for the specific concentration.)
• Klon-Bezeichnung: [LN3]
• Isotyp: IgG2b
• NCBI: 3122
• UniProt: Q30154, P01912, P01911, Q29974, P79483, P01903, P13762
• Puffer: 10mM NaH2PO4, 150mM NaCl, 0.1% Gelatin, 0.09% Sodium azide.
• Formulierung: Liquid

Anwendungsbeschreibung

• Anwendungsbeschreibung: FCM: 0.25 µg (5 µl) for 105-108 cells in 100 µl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.